StonvexLoading…
StonvexCore line items from BBBY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.04B | $1.39B | $1.56B | $1.93B |
Operating Income | $-61.21M | $-184.09M | $-143.98M | $27.01M |
Net Income | $-84.62M | $-258.80M | $-307.84M | $-35.24M |
EPS (Diluted) | $-1.41 | $-5.56 | $-6.81 | $-0.83 |
Total Assets | $425.48M | $401.95M | $635.82M | $878.55M |
Total Liabilities | $207.53M | $239.22M | $276.69M | $232.72M |
Cash & Equivalents | $175.29M | $159.17M | $302.61M | $371.26M |
Free Cash Flow OCF − CapEx | $-64.11M | $-188.62M | $-37.77M | $-27.43M |
Shares Outstanding | 68.86M | 53.07M | 45.41M | 44.95M |